Publication | Closed Access

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis

Critical Care MedicineSevere SepsisControlled TrialAcute CarePatient SafetySepsisBeta-lactam InfusionPharmacotherapyMedicineCritical Emergency MedicineEmergency Medicine